Investing.com - Genmab AS reported on Wednesday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Genmab AS announced earnings per share of $0.13 on revenue of $271.12M. Analysts polled by Investing.com anticipated EPS of $0.09 on revenue of $232.05M.
Genmab AS shares are up 70.31% from the beginning of the year and are trading at $38.03 , down-from-52-week-high.They are outperforming the Nasdaq which is up 29.18% from the start of the year.
Genmab AS follows other major sector earnings this month
Genmab AS's report follows an earnings beat by Industrial Commercial Bank of China on Friday, who reported EPS of $0.66 on revenue of $29.54B, compared to forecasts EPS of $0.49 on revenue of $28.59B.
China Construction Bank Corp had beat expectations on Thursday, October 29, 2020 with third quarter EPS of $0.81 on revenue of $26.74B, compared to forecast for EPS of $0.75 on revenue of $25.24B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar